Trafalgar International GCAN
GCAN
$0.75 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Cash & Current Investments (2017 - 2026)

Updated

Trafalgar International (GCAN) posted Cash & Current Investments of $1,439 for Q1 2026, down 96.9% from $46,213 a year earlier but up 76.6% from the prior quarter.

Analysis

Trafalgar International (GCAN) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, Trafalgar International's Cash & Current Investments came in at $815.00, down 98.6% from FY2024.

  • Annual Cash & Current Investments has declined for four consecutive years, with a five-year compound annual growth rate of -62.7% (FY2020 to FY2025).
  • In prior years, Trafalgar International's Cash & Current Investments was $57,368 in FY2024 (-65.6%), $166,859 in FY2023 (-38.2%), $270,030 in FY2022 (-28.5%) and $377,520 in FY2021 (+234.2%).
  • Quarterly Cash & Current Investments has run from a low of $815.00 in Q4 2025 to a high of $528,930 in Q2 2021 over five years.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last 16 quarters, with an average decline of 74.2% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2021, with growth of 234.2%; the weakest was Q4 2025, with a decline of 98.6%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $815.00 (Q4 2025), $21,355 (Q3 2025) and $26,712 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Trafalgar International 708,701.25 658,380.25 - 1,439.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,439.00
Dec 31, 2025 815.00
Sep 30, 2025 21,355.00
Jun 30, 2025 26,712.00
Mar 31, 2025 46,213.00
Dec 31, 2024 57,368.00
Sep 30, 2024 62,282.00
Jun 30, 2024 80,316.00
Mar 31, 2024 129,323.00
Dec 31, 2023 166,859.00
Sep 30, 2023 199,532.00
Jun 30, 2023 240,747.00
Mar 31, 2023 251,553.00
Dec 31, 2022 270,030.00
Sep 30, 2022 289,094.00
Jun 30, 2022 311,197.00
Mar 31, 2022 367,589.00
Dec 31, 2021 377,520.00
Sep 30, 2021 456,358.00
Jun 30, 2021 528,930.00
API Access

Trafalgar International Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GCAN&period=max&api_key=YOUR_API_KEY